IU Health Simon Cancer Center Clinical Research
At the Indiana University Health Simon Cancer Center, the physicians treating patients in the clinics interact with the scientists conducting clinical trials and investigating cancer in the laboratories. In all, more than 200 physicians and researchers are working to develop cures for cancer.
That teamwork leads to clinical breakthroughs, such as turning the cure rate of testicular cancer from 10 percent to nearly 95 percent today, among many others.
Clinical trials are research studies in which people, either with a high risk for cancer or diagnosis of the disease, help physicians find ways to improve healthcare and cancer treatment. Each study tries to answer scientific questions and find better ways to prevent, diagnose or treat cancer as well as improve quality of life for cancer survivors.
More than 100 scientists, physicians, nurses, social workers and technologists at the Indiana University Health Melvin and Bren Simon Cancer Center are dedicated to advancing cancer care and treatment through clinical trials.
Standard therapy does not help all cancer patients. In addition, researchers at IU Health Melvin and Bren Simon Cancer Center continue their search for new treatments and, hopefully, new cures. Today’s clinical trials are tomorrow’s standard therapies.
Clinical Trials
Clinical trials are research studies in which people, either with a high risk for cancer or diagnosis of the disease, help physicians find ways to improve healthcare and cancer treatment. Each study tries to answer scientific questions and find better ways to prevent, diagnose or treat cancer as well as improve quality of life for cancer survivors.
More than 100 scientists, physicians, nurses, social workers and technologists at the Indiana University Health Melvin and Bren Simon Cancer Center are dedicated to advancing cancer care and treatment through clinical trials.
Standard therapy does not help all cancer patients. In addition, researchers at IU Health Melvin and Bren Simon Cancer Center continue their search for new treatments and, hopefully, new cures. Today’s clinical trials are tomorrow’s standard therapies.
